101 related articles for article (PubMed ID: 6355293)
1. Suppression of humoral immune responses by synthetic C3a peptides.
Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxin-mediated regulation of human and murine immune responses.
Morgan EL; Weigle WO; Hugli TE
Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the immune response by anaphylatoxins.
Morgan EL
Complement; 1986; 3(3):128-36. PubMed ID: 3542364
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of secondary in vitro antibody responses by the third component of complement.
Hobbs MV; Feldbush TL; Needleman BW; Weiler JM
J Immunol; 1982 Mar; 128(3):1470-5. PubMed ID: 6460062
[TBL] [Abstract][Full Text] [Related]
5. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
Morgan EL; Weigle WO; Hugli TE
J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
[TBL] [Abstract][Full Text] [Related]
6. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
[TBL] [Abstract][Full Text] [Related]
7. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
8. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
Hugli TE; Erickson BW
Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
[TBL] [Abstract][Full Text] [Related]
11. The active site of C3a anaphylatoxin.
Caporale LH; Tippett PS; Erickson BW; Hugli TE
J Biol Chem; 1980 Nov; 255(22):10758-63. PubMed ID: 6968751
[TBL] [Abstract][Full Text] [Related]
12. Synthetic C3a analogs as specific inhibitors of C3a activity.
Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of the anaphylatoxins.
Hugli TE
Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
Wieczorek Z; Słoń J; Siemion IZ
Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
[TBL] [Abstract][Full Text] [Related]
15. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
16. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
Unson CG; Erickson BW; Hugli TE
Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
[TBL] [Abstract][Full Text] [Related]
17. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
[TBL] [Abstract][Full Text] [Related]
18. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
19. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
Huey R; Erickson BW; Bloor CM; Hugli TE
Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive activity of alanine analogs of cyclolinopeptide A.
Wieczorek Z; Zimecki M; Pedyczak A; Lisowski M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):291-6. PubMed ID: 8010868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
